[Translation] A randomized, double-blind trial comparing the effects of dulaglutide 1.5 mg versus placebo on glycemic control in Chinese patients with type 2 diabetes receiving titrated basal insulin
H9X-MC-GBGO(GBGO)研究的目的是,在接受滴定基础甘精胰岛素(伴二甲
双胍和/或阿卡波糖)治疗的中国成人2 型糖尿病(T2D)患者中,评估联合使用每周
一次(QW)度拉糖肽或联合使用安慰剂QW对血糖控制的有效性和安全性。
[Translation] The purpose of the H9X-MC-GBGO (GBGO) study was to evaluate the efficacy and safety of dulaglutide once weekly (QW) or placebo QW on glycemic control in Chinese adults with type 2 diabetes (T2D) receiving titrated basal insulin glargine (with metformin and/or acarbose).